{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T01:30:31Z","timestamp":1794274231500,"version":"4.9.0"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T00:00:00Z","timestamp":1604620800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims\u2003<\/jats:title>\n                  <jats:p>Our aim was to assess the risk of cardiovascular disease (CVD) mortality in US 5-year survivors of adolescent and young adult (AYA) cancer compared with those of the general population and contemporaneous 5-year survivors of childhood cancer.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results\u2003<\/jats:title>\n                  <jats:p>A total of 160 834 5-year AYA cancer survivors (aged 15\u201339 years at diagnosis) were included, representing 2 239 390 person-years of follow-up. Overall, 2910 CVD deaths occurred, which was 1.4-fold [95% confidence interval (CI) 1.3\u20131.4] that expected in the general population, corresponding to 3.6 (95% CI 3.2\u20133.9) excess CVD deaths per 10 000 person-years. The highest risk of cardiac mortality was experienced after Hodgkin\u2019s lymphoma (HL), and the highest risk of cerebrovascular mortality was observed with central nervous system (CNS) tumours. Even survivors in their 6th and 7th decades of life, the risk of CVD mortality remained markedly higher than that of the matched general population. Competing risk analysis showed that the cumulative mortality of CVD was elevated among AYA cancer survivors compared with childhood cancer survivors during the whole study period.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion\u2003<\/jats:title>\n                  <jats:p>Long-term AYA cancer survivors have a greater risk of CVD mortality than the US general population and childhood cancer survivors. Vulnerable subgroups, especially survivors of HL and CNS tumours, require continued close follow-up care for cardiovascular conditions throughout survivorship.<\/jats:p>\n                  <jats:p\/>\n               <\/jats:sec>","DOI":"10.1093\/eurheartj\/ehaa779","type":"journal-article","created":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T19:26:11Z","timestamp":1599679571000},"page":"101-109","source":"Crossref","is-referenced-by-count":73,"title":["Long-term cardiovascular disease mortality among 160 834 5-year survivors of adolescent and young adult cancer: an American population-based cohort study"],"prefix":"10.1093","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9013-658X","authenticated-orcid":false,"given":"Lai","family":"Wang","sequence":"first","affiliation":[{"name":"Departments of Integrative Oncology, Fudan University Shanghai Cancer Center , 270 Dong An Road, Shanghai 200032, China"},{"name":"Department of Oncology, Shanghai Medical College, Fudan University , 130 Dong An Road, Shanghai 200032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengjiao","family":"Wang","sequence":"additional","affiliation":[{"name":"Departments of Integrative Oncology, Fudan University Shanghai Cancer Center , 270 Dong An Road, Shanghai 200032, China"},{"name":"Department of Oncology, Shanghai Medical College, Fudan University , 130 Dong An Road, Shanghai 200032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianyu","family":"Chen","sequence":"additional","affiliation":[{"name":"Departments of Integrative Oncology, Fudan University Shanghai Cancer Center , 270 Dong An Road, Shanghai 200032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawen","family":"Geng","sequence":"additional","affiliation":[{"name":"Departments of Integrative Oncology, Fudan University Shanghai Cancer Center , 270 Dong An Road, Shanghai 200032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shulin","family":"Yu","sequence":"additional","affiliation":[{"name":"Departments of Integrative Oncology, Fudan University Shanghai Cancer Center , 270 Dong An Road, Shanghai 200032, China"},{"name":"Department of Oncology, Shanghai Medical College, Fudan University , 130 Dong An Road, Shanghai 200032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4502-0801","authenticated-orcid":false,"given":"Zhen","family":"Chen","sequence":"additional","affiliation":[{"name":"Departments of Integrative Oncology, Fudan University Shanghai Cancer Center , 270 Dong An Road, Shanghai 200032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,11,6]]},"reference":[{"key":"2022102513383824200_ehaa779-B1","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3322\/caac.21585","article-title":"Adolescent and young adult oncology-past, present, and future","volume":"69","author":"Close","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"2022102513383824200_ehaa779-B2","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1093\/annonc\/mdr044","article-title":"Late effects in survivors of teenage and young adult cancer: does age matter?","volume":"22","author":"Woodward","year":"2011","journal-title":"Ann Oncol"},{"key":"2022102513383824200_ehaa779-B3","doi-asserted-by":"crossref","first-page":"66","DOI":"10.6004\/jnccn.2018.0001","article-title":"Adolescent and young adult oncology, Version 2.2018, NCCN clinical practice guidelines in oncology","volume":"16","author":"Coccia","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"key":"2022102513383824200_ehaa779-B4","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.001891","article-title":"Treatment, behavioral, and psychosocial components of cardiovascular disease risk among survivors of childhood and young adult cancer","volume":"4","author":"Berkman","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"2022102513383824200_ehaa779-B5","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1161\/CIR.0b013e3182a88099","article-title":"Long-term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: pathophysiology, course, monitoring, management, prevention, and research directions: a scientific statement from the American Heart Association","volume":"128","author":"Lipshultz","year":"2013","journal-title":"Circulation"},{"key":"2022102513383824200_ehaa779-B6","doi-asserted-by":"crossref","first-page":"dju110","DOI":"10.1093\/jnci\/dju110","article-title":"Cardiovascular disease in survivors of adolescent and young adult cancer: a Danish cohort study, 1943-2009","volume":"106","author":"Rugbjerg","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"2022102513383824200_ehaa779-B7","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1200\/JCO.2015.65.5845","article-title":"Cardiovascular disease risk profiles in survivors of adolescent and young adult (AYA) cancer: the Kaiser Permanente AYA Cancer Survivors Study","volume":"34","author":"Chao","year":"2016","journal-title":"J Clin Oncol"},{"key":"2022102513383824200_ehaa779-B8","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/pbc.23296","article-title":"Long-term non-cancer mortality in pediatric and young adult cancer survivors in Finland","volume":"58","author":"Prasad","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"2022102513383824200_ehaa779-B9","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1002\/ijc.29135","article-title":"Late mortality among 5-year survivors of early onset cancer: a population-based register study","volume":"136","author":"Kero","year":"2015","journal-title":"Int J Cancer"},{"key":"2022102513383824200_ehaa779-B10","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1161\/CIRCULATIONAHA.116.022514","article-title":"Cardiac mortality among 200 000 five-year survivors of cancer diagnosed at 15 to 39 years of age: the teenage and young adult cancer survivor study","volume":"134","author":"Henson","year":"2016","journal-title":"Circulation"},{"key":"2022102513383824200_ehaa779-B11","volume-title":"SEER Cancer Statistics Review, 1975-2016","author":"Howlader","year":"2019"},{"key":"2022102513383824200_ehaa779-B12","year":"2019"},{"key":"2022102513383824200_ehaa779-B13","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1002\/cncr.21773","article-title":"Classification schemes for tumors diagnosed in adolescents and young adults","volume":"106","author":"Barr","year":"2006","journal-title":"Cancer"},{"key":"2022102513383824200_ehaa779-B14","year":"2018"},{"key":"2022102513383824200_ehaa779-B15","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/pbc.24445","article-title":"A worldwide collaboration to harmonize guidelines for the long-term follow-up of childhood and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group","volume":"60","author":"Kremer","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"2022102513383824200_ehaa779-B16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/ejhf.654","article-title":"2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: the Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC","volume":"19","author":"Zamorano","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2022102513383824200_ehaa779-B17","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","article-title":"2016 European Guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the","volume":"37","author":"Piepoli","year":"2016","journal-title":"Eur Heart J"},{"key":"2022102513383824200_ehaa779-B18","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1001\/jamainternmed.2015.1180","article-title":"Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk","volume":"175","author":"van Nimwegen","year":"2015","journal-title":"JAMA Intern Med"},{"key":"2022102513383824200_ehaa779-B19","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1161\/CIRCULATIONAHA.116.025778","article-title":"Risk of cerebrovascular events in 178\u2009962 five-year survivors of cancer diagnosed at 15 to 39 years of age: the TYACSS (Teenage and Young Adult Cancer Survivor Study","volume":"135","author":"Bright","year":"2017","journal-title":"Circulation"},{"key":"2022102513383824200_ehaa779-B20","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ijc.28385","article-title":"Cardiovascular morbidity in long-term survivors of early-onset cancer: a population-based study","volume":"134","author":"Kero","year":"2014","journal-title":"Int J Cancer"},{"key":"2022102513383824200_ehaa779-B21","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejca.2018.12.021","article-title":"Late mortality and causes of death among 5-year survivors of childhood cancer diagnosed in the period 1960-1999 and registered in the Italian Off-Therapy Registry","volume":"110","author":"Bagnasco","year":"2019","journal-title":"Eur J Cancer"},{"key":"2022102513383824200_ehaa779-B22","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1161\/CIRCULATIONAHA.116.024811","article-title":"Population-based long-term cardiac-specific mortality among 34\u2009489 five-year survivors of childhood cancer in Great Britain","volume":"135","author":"Fidler","year":"2017","journal-title":"Circulation"},{"key":"2022102513383824200_ehaa779-B23","doi-asserted-by":"crossref","first-page":"i4351","DOI":"10.1136\/bmj.i4351","article-title":"Long term cause specific mortality among 34 489 five year survivors of childhood cancer in Great Britain: population based cohort study","volume":"354","author":"Fidler","year":"2016","journal-title":"BMJ"},{"key":"2022102513383824200_ehaa779-B24","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1200\/JCO.2008.21.1425","article-title":"Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study","volume":"27","author":"Armstrong","year":"2009","journal-title":"J Clin Oncol"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/42\/1\/101\/46624147\/ehaa779.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/42\/1\/101\/46624147\/ehaa779.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T16:52:39Z","timestamp":1666716759000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/42\/1\/101\/5959817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,6]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,11,6]]},"published-print":{"date-parts":[[2021,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehaa779","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,1,1]]},"published":{"date-parts":[[2020,11,6]]}}}